Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: Final results of a multinational phase III trial (TROPIC)

Date
2010
Author
Matthews, P.
Sartor, A. O.
De Bono, J. S.
Oudard, S.
Ozguroglu, M.
Hansen, S.
Machiels, J. H.
Shen, L.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/24968
https://doi.org/10.1200/jco.2010.28.15_suppl.4508
Collections